Clinical Trials Browser

Phase NA × Withdrawn × Endometrial Neoplasms × Clear all

NCT07226102 2026-02-04

Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer

Genital Neoplasms, Female, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05850663 2026-02-03

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Phase NA Withdrawn

GynecologicHead & Neck

Uterine Cervical Neoplasms, Head and Neck Neoplasms, Endometrial Neoplasms

NCT03238053 2024-10-16

Laser Treatment of Genito-urinary Syndrome in Women

Phase NA Withdrawn

BreastGenitourinaryGynecologic

Breast Neoplasms, Vaginitis, Endometrial Neoplasms, Urinary Bladder, Overactive

NCT00499291 2023-05-25

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Phase NA Withdrawn

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT01888562 2015-12-18

Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma

Phase NA Withdrawn

Gynecologic

Endometrial Neoplasms